2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
199
Breast Neoplasms
111
Carcinoma, Non-Small-Cell Lung
94
Triple Negative Breast Neoplasms
66
Neoplasm Metastasis
44
Neoplasms
42
Lung Neoplasms
25
Squamous Cell Carcinoma of Head and Neck
24
Colorectal Neoplasms
18
Stomach Neoplasms
17
Esophageal Squamous Cell Carcinoma
17
Adenocarcinoma
17
Melanoma
15
Head and Neck Neoplasms
15
Ovarian Neoplasms
12
Cholangiocarcinoma
11
Carcinoma
11
Parkinson Disease 4, Autosomal Dominant Lewy Body
10
Gallbladder Neoplasms
10
Esophageal Neoplasms
10
Carcinoma, Pancreatic Ductal
10
Small Cell Lung Carcinoma
9
Sarcoma
9
Fallopian Tube Neoplasms
9
Biliary Tract Neoplasms
9
Carcinoma, Squamous Cell
8
Neoplasms by Site
7
Pancreatic Diseases
6
Pancreatic Adenocarcinoma
6
Digestive System Neoplasms
6
Interventions
Blood Specimen Collection
29
Reverse Transcriptase Polymerase Chain Reaction
7
Flow Cytometry
7
Surgical Procedures, Operative
4
Liquid Biopsy
4
cabazitaxel
3
Trastuzumab
3
Propofol
3
Carboplatin
3
Bevacizumab
3
Standard of Care
2
Spinal Puncture
2
Sevoflurane
2
Positron Emission Tomography Computed Tomography
2
Pirinitramide
2
Neoadjuvant Therapy
2
Morphine
2
Laparoscopy
2
Hematologic Tests
2
Gemcitabine
2
Folfox protocol
2
Epirubicin
2
Drug Therapy
2
Docetaxel
2
Cyclophosphamide
2
Cisplatin
2
Cetuximab
2
Capecitabine
2
Aspirin
2
Anesthesia, General
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplastic Cells, Circulating
×
130-nm albumin-bound paclitaxel
×
Clear all
NCT02707159
2023-03-08
PACT-ACT-v6
Helse Stavanger HF
Phase 2
Completed
70 enrolled